OpenSAFELY Vaccine Coverage Report
AstraZeneca / Priority Group 4
Data from combined, up to 2021-03-17.
| Vaccinated at 2021-03-17 (%) | Vaccinated at 2021-03-17 (n) | Population | Vaccinated at 2021-03-10 (%) | Vaccinated in past week (%) | ||
|---|---|---|---|---|---|---|
| Overall | - | 55.3% | 2,593,864 | 4,690,203 | 54.3% | 1.0% |
| Sex | Female | 54.7% | 1,379,987 | 2,523,549 | 53.6% | 1.1% |
| Male | 56.0% | 1,213,877 | 2,166,654 | 55.1% | 0.9% | |
| Ethnicity | White - British | 58.7% | 1,503,110 | 2,561,699 | 58.0% | 0.6% |
| White - Irish | 52.1% | 14,644 | 28,098 | 51.5% | 0.6% | |
| White - Any other White background | 42.3% | 61,831 | 146,111 | 41.0% | 1.3% | |
| Mixed - White and Black Caribbean | 37.2% | 4,403 | 11,830 | 35.6% | 1.7% | |
| Mixed - White and Black African | 38.0% | 4,627 | 12,180 | 35.3% | 2.7% | |
| Mixed - White and Asian | 45.4% | 3,465 | 7,637 | 43.3% | 2.1% | |
| Mixed - Any other mixed background | 40.6% | 6,279 | 15,470 | 38.8% | 1.8% | |
| Asian or Asian British - Indian | 48.6% | 59,290 | 121,926 | 46.5% | 2.2% | |
| Asian or Asian British - Pakistani | 42.5% | 41,615 | 97,874 | 38.6% | 3.9% | |
| Asian or Asian British - Bangladeshi | 51.6% | 25,641 | 49,658 | 46.9% | 4.7% | |
| Asian or Asian British - Any other Asian background | 44.6% | 28,735 | 64,484 | 42.2% | 2.3% | |
| Black or Black British - Caribbean | 34.8% | 14,917 | 42,903 | 32.8% | 2.0% | |
| Black or Black British - African | 36.1% | 37,541 | 103,908 | 33.2% | 3.0% | |
| Black or Black British - Any other Black background | 34.2% | 6,454 | 18,858 | 31.8% | 2.4% | |
| Other ethnic groups - Chinese | 45.5% | 6,356 | 13,958 | 43.9% | 1.6% | |
| Other ethnic groups - Any other ethnic group | 40.6% | 15,911 | 39,158 | 38.4% | 2.3% | |
| Patients with any other ethnicity code | 56.2% | 349,580 | 621,894 | 55.3% | 0.9% | |
| Ethnicity not stated | 55.8% | 15,911 | 28,518 | 54.8% | 1.0% | |
| Ethnicity not recorded | 55.9% | 393,428 | 703,941 | 55.0% | 0.9% | |
| Ethnicity (broad categories) | White | 57.7% | 1,579,599 | 2,735,929 | 57.1% | 0.7% |
| Mixed | 39.9% | 18,802 | 47,131 | 37.8% | 2.1% | |
| South Asian | 46.5% | 155,309 | 333,956 | 43.4% | 3.1% | |
| Black | 35.6% | 58,926 | 165,683 | 32.9% | 2.6% | |
| Other | 41.9% | 22,281 | 53,116 | 39.9% | 2.1% | |
| Unknown | 56.0% | 758,926 | 1,354,360 | 55.1% | 0.9% | |
| Index of Multiple Deprivation | 1 (most deprived) | 50.4% | 499,079 | 989,849 | 48.6% | 1.9% |
| 2 | 52.9% | 500,878 | 945,966 | 51.6% | 1.3% | |
| 3 | 56.4% | 526,085 | 933,114 | 55.6% | 0.8% | |
| 4 | 58.0% | 523,096 | 902,132 | 57.4% | 0.6% | |
| 5 (least deprived) | 59.4% | 521,038 | 876,498 | 59.0% | 0.4% | |
| Unknown | 55.5% | 23,653 | 42,623 | 54.4% | 1.1% | |
| Clinical Risk Groups | Patients in Any Clinical Risk Group | 54.4% | 1,635,508 | 3,009,034 | 53.0% | 1.3% |
| Patients with Immunosuppression | 54.1% | 234,822 | 434,063 | 53.3% | 0.8% | |
| Patients with CKD | 57.6% | 236,873 | 411,054 | 57.0% | 0.6% | |
| Patients who have Chronic Respiratory Disease | 57.8% | 340,627 | 588,854 | 57.2% | 0.7% | |
| Patients with Diabetes | 51.2% | 700,322 | 1,367,464 | 49.0% | 2.2% | |
| Patients with Chronic Liver disease | 54.8% | 116,109 | 211,890 | 53.4% | 1.4% | |
| Patients with CNS Disease (including Stroke/TIA) | 57.8% | 238,672 | 412,881 | 56.9% | 0.9% | |
| Patients with Chronic heart disease | 58.3% | 545,930 | 936,236 | 57.7% | 0.7% | |
| Patients with Asplenia or Dysfunction of the Spleen | 51.3% | 42,504 | 82,887 | 50.6% | 0.7% | |
| Patients with Wider Learning Disability | 54.0% | 30,373 | 56,259 | 51.9% | 2.0% | |
| Patients with Severe Mental Health | 51.9% | 40,579 | 78,183 | 49.7% | 2.2% | |
| Other Groups | Patients who are shielding (High Risk from COVID-19) | 50.7% | 1,158,122 | 2,282,994 | 48.9% | 1.8% |
| Patients with Morbid Obesity | 53.0% | 176,820 | 333,921 | 51.0% | 1.9% | |
| Patients who are pregnant | 22.5% | 6,433 | 28,588 | 19.7% | 2.8% |